@article {Ellinghaus2020.05.31.20114991, author = {David Ellinghaus and Frauke Degenhardt and Luis Bujanda and Maria Buti and Agust{\'\i}n Albillos and Pietro Invernizzi and Javier Fern{\'a}ndez and Daniele Prati and Guido Baselli and Rosanna Asselta and Marit M Grimsrud and Chiara Milani and F{\'a}tima Aziz and Jan K{\"a}ssens and Sandra May and Mareike Wendorff and Lars Wienbrandt and Florian Uellendahl-Werth and Tenghao Zheng and Xiaoli Yi and Ra{\'u}l de Pablo and Adolfo Garrido Chercoles and Graduate in Chemistry and Adriana Palom and Alba-Estela Garcia-Fernandez and Francisco Rodriguez-Frias and Alberto Zanella and Alessandra Bandera and Alessandro Protti and Alessio Aghemo and Ana Lleo and Andrea Biondi and Andrea Caballero-Garralda and Andrea Gori and Anja Tanck and Anna Latiano and Anna Ludovica Fracanzani and Anna Peschuk and Antonio Juli{\`a} and Antonio Pesenti and Antonio Voza and David Jim{\'e}nez and Beatriz Mateos and Beatriz Nafria Jimenez and Graduate in Biotechnology and Carmen Quereda and Claudio Angelini and Cristina Cea and Aurora Solier and David Pesta{\~n}a and Elena Sandoval and Elvezia Maria Paraboschi and Enrique Navas and Ferruccio Ceriotti and Filippo Martinelli-Boneschi and Flora Peyvandi and Francesco Blasi and Luis T{\'e}llez and Albert Blanco-Grau and Giacomo Grasselli and Giorgio Costantino and Giulia Cardamone and Giuseppe Foti and Serena Aneli and Hayato Kurihara and Hesham ElAbd and Ilaria My and Javier Martin and Jeanette Erdmann and Jos{\'e} Ferrusqu{\'\i}a-Acosta and Koldo Garcia-Etxebarria and Laura Izquierdo-Sanchez and Graduate in Biochemistry, MS and Laura Rachele Bettini and Leonardo Terranova and Leticia Moreira and Luigi Santoro and Luigia Scudeller and Francisco Mesonero and Luisa Roade and Marco Schaefer and Maria Carrabba and Maria del Mar Riveiro Barciela and Maria Eloina Figuera Basso and Maria Grazia Valsecchi and Mar{\'\i}a Hernandez-Tejero and Marialbert Acosta-Herrera and Mariella D{\textquoteright}Angi{\`o} and Marina Baldini and Marina Cazzaniga and Martin Schulzky and Maurizio Cecconi and Michael Wittig and Michele Ciccarelli and Miguel Rodr{\'\i}guez-Gand{\'\i}a and Monica Bocciolone and Monica Miozzo and Nicole Braun and Nilda Mart{\'\i}nez and Orazio Palmieri and Paola Faverio and Paoletta Preatoni and Paolo Bonfanti and Paolo Omodei and Paolo Tentorio and Pedro Castro and Pedro M. Rodrigues and Aaron Blandino Ortiz and Ricardo Ferrer Roca and Roberta Gualtierotti and Rosa Nieto and Salvatore Badalamenti and Sara Marsal and Giuseppe Matullo and Serena Pelusi and Valter Monzani and Tanja Wesse and Tomas Pumarola and Valeria Rimoldi and Silvano Bosari and Wolfgang Albrecht and Wolfgang Peter and Manuel Romero G{\'o}mez and Mauro D{\textquoteright}Amato and Stefano Duga and Jesus M. Banales and Johannes R Hov and Trine Folseraas and Luca Valenti and Andre Franke and Tom H Karlsen}, title = {The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis}, elocation-id = {2020.05.31.20114991}, year = {2020}, doi = {10.1101/2020.05.31.20114991}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Respiratory failure is a key feature of severe Covid-19 and a critical driver of mortality, but for reasons poorly defined affects less than 10\% of SARS-CoV-2 infected patients.Methods We included 1,980 patients with Covid-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian and Barcelona) for a genome-wide association analysis. After quality control and exclusion of population outliers, 835 patients and 1,255 population-derived controls from Italy, and 775 patients and 950 controls from Spain were included in the final analysis. In total we analyzed 8,582,968 single-nucleotide polymorphisms (SNPs) and conducted a meta-analysis of both case-control panels.Results We detected cross-replicating associations with rs11385942 at chromosome 3p21.31 and rs657152 at 9q34, which were genome-wide significant (P\<5{\texttimes}10-8) in the meta-analysis of both study panels, odds ratio [OR], 1.77; 95\% confidence interval [CI], 1.48 to 2.11; P=1.14{\texttimes}10-10 and OR 1.32 (95\% CI, 1.20 to 1.47; P=4.95{\texttimes}10-8), respectively. Among six genes at 3p21.31, SLC6A20 encodes a known interaction partner with angiotensin converting enzyme 2 (ACE2). The association signal at 9q34 was located at the ABO blood group locus and a blood-group-specific analysis showed higher risk for A-positive individuals (OR=1.45, 95\% CI, 1.20 to 1.75, P=1.48{\texttimes}10-4) and a protective effect for blood group O (OR=0.65, 95\% CI, 0.53 to 0.79, P=1.06{\texttimes}10-5).Conclusions We herein report the first robust genetic susceptibility loci for the development of respiratory failure in Covid-19. Identified variants may help guide targeted exploration of severe Covid-19 pathophysiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe IKMB{\textquoteright}s core facilities received infrastructure support by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI, EXC2167). The project also received support through a philanthropic donation by Stein Erik Hagen and Canica AS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The following ethical approvals of the project were obtained from the relevant ethics committees: Germany: Kiel (reference number D464/20); Italy: Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico (reference number 342_2020 and 334-2020 for cases and controls, respectively), Humanitas Clinical and Research Center, IRCCS (reference number 316/20), San Gerardo Hospital School of Medicine, Monza (the ethics committee of the National Institute of Infectious Diseases Lazzarro Spallanzani reference number 84/2020); Norway: Regional Committee for Medical and Health Research Ethics in South-Eastern Norway (reference number 132550); Spain: Hospital Clinic and IDIBAPS, Barcelona (reference number HCB/2020/0405), Hospital Universitario Vall d{\textquoteright}Hebron, Barcelona (reference PR[AG]244/2020), Hospital Universitario Ramon y Cajal, Madrid (reference number 093/20), Donostia University Hospital, San Sebastian (reference number PI2020064).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics will be made available upon request and after signing of appropriate institutional data transfer agreements, after acceptance of the peer-reviewed manuscript.}, URL = {https://www.medrxiv.org/content/early/2020/06/02/2020.05.31.20114991}, eprint = {https://www.medrxiv.org/content/early/2020/06/02/2020.05.31.20114991.full.pdf}, journal = {medRxiv} }